The company has expanded its international business with a new product introduction in the United States market. The move reflects its strategy of strengthening regulated market exposure and improving portfolio depth.
Indian pharmaceutical businesses continue increasing focus on complex products and international expansion to maintain growth.
Industry experts believe sustained investment in product development remains critical for long-term competitiveness.
